| 0 |
CLINICAL TRIAL PARTICIPANT |
21 |
0.3684 |
| 1 |
MASKED FEVER |
5 |
0.3571 |
| 2 |
PULMONARY TRICHOSPORONOSIS |
8 |
0.3478 |
| 3 |
COVID-19 TREATMENT |
21 |
0.3088 |
| 4 |
MITRAL PERFORATION |
4 |
0.2500 |
| 5 |
LACTOBACILLUS BACTERAEMIA |
4 |
0.1905 |
| 6 |
SARS-COV-2 RNA INCREASED |
11 |
0.1618 |
| 7 |
PARAVENOUS DRUG ADMINISTRATION |
6 |
0.1395 |
| 8 |
COINFECTION |
9 |
0.1304 |
| 9 |
RHINOCEREBRAL MUCORMYCOSIS |
39 |
0.1124 |
| 10 |
CRYPTOCOCCAL MENINGOENCEPHALITIS |
13 |
0.0992 |
| 11 |
PNEUMONIA SERRATIA |
4 |
0.0870 |
| 12 |
CUTANEOUS MUCORMYCOSIS |
15 |
0.0815 |
| 13 |
BRONCHOPLEURAL FISTULA |
29 |
0.0771 |
| 14 |
ISOSPORIASIS |
6 |
0.0769 |
| 15 |
HEPATIC AMOEBIASIS |
5 |
0.0746 |
| 16 |
OCULOAURICULOVERTEBRAL DYSPLASIA |
5 |
0.0694 |
| 17 |
PULMONARY MUCORMYCOSIS |
36 |
0.0682 |
| 18 |
LUNG ASSIST DEVICE THERAPY |
4 |
0.0645 |
| 19 |
BORDETELLA INFECTION |
5 |
0.0556 |
| 20 |
RENAL REPLACEMENT THERAPY |
7 |
0.0547 |
| 21 |
MESENTERIC HAEMORRHAGE |
4 |
0.0465 |
| 22 |
AMOEBIC COLITIS |
4 |
0.0440 |
| 23 |
NATURAL KILLER CELL COUNT DECREASED |
4 |
0.0435 |
| 24 |
HUMORAL IMMUNE DEFECT |
16 |
0.0431 |
| 25 |
COVID-19 PNEUMONIA |
505 |
0.0427 |
| 26 |
MYCOTIC ENDOPHTHALMITIS |
8 |
0.0423 |
| 27 |
GASTROINTESTINAL MUCORMYCOSIS |
7 |
0.0419 |
| 28 |
HERPES SIMPLEX REACTIVATION |
15 |
0.0394 |
| 29 |
DRUG RESISTANCE MUTATION |
7 |
0.0393 |
| 30 |
PNEUMOMEDIASTINUM |
71 |
0.0392 |
| 31 |
CEREBRAL NOCARDIOSIS |
9 |
0.0386 |
| 32 |
DISSEMINATED ASPERGILLOSIS |
18 |
0.0381 |
| 33 |
PULMONARY NECROSIS |
12 |
0.0352 |
| 34 |
CRYPTOCOCCAL FUNGAEMIA |
5 |
0.0350 |
| 35 |
INTESTINAL BARRIER DYSFUNCTION |
4 |
0.0345 |
| 36 |
ACQUIRED MACROGLOSSIA |
3 |
0.0337 |
| 37 |
SUBCUTANEOUS EMPHYSEMA |
33 |
0.0336 |
| 38 |
BAROTRAUMA |
3 |
0.0326 |
| 39 |
MUCORMYCOSIS |
84 |
0.0323 |
| 40 |
HAEMORRHAGIC CHOLECYSTITIS |
4 |
0.0320 |
| 41 |
DISSEMINATED STRONGYLOIDIASIS |
7 |
0.0320 |
| 42 |
PNEUMONIA CRYPTOCOCCAL |
30 |
0.0317 |
| 43 |
DIVERTICULITIS INTESTINAL PERFORATED |
11 |
0.0308 |
| 44 |
DISSEMINATED MUCORMYCOSIS |
12 |
0.0305 |
| 45 |
ASPERGILLUS TEST POSITIVE |
9 |
0.0292 |
| 46 |
DISSEMINATED CRYPTOCOCCOSIS |
22 |
0.0291 |
| 47 |
CYSTIC LUNG DISEASE |
4 |
0.0282 |
| 48 |
MYOPATHY TOXIC |
17 |
0.0275 |
| 49 |
ACINETOBACTER BACTERAEMIA |
5 |
0.0266 |
| 50 |
BRONCHOPULMONARY ASPERGILLOSIS |
206 |
0.0265 |
| 51 |
PULMONARY AIR LEAKAGE |
4 |
0.0265 |
| 52 |
SUPERINFECTION BACTERIAL |
21 |
0.0265 |
| 53 |
HAEMOFILTRATION |
5 |
0.0263 |
| 54 |
SPONTANEOUS BACTERIAL PERITONITIS |
6 |
0.0246 |
| 55 |
BURKHOLDERIA TEST POSITIVE |
3 |
0.0242 |
| 56 |
INFECTION REACTIVATION |
27 |
0.0236 |
| 57 |
ACUTE RIGHT VENTRICULAR FAILURE |
4 |
0.0235 |
| 58 |
ISCHAEMIC HEPATITIS |
32 |
0.0234 |
| 59 |
CYTOKINE STORM |
16 |
0.0234 |
| 60 |
CHEST WALL HAEMATOMA |
6 |
0.0233 |
| 61 |
B-CELL APLASIA |
6 |
0.0233 |
| 62 |
POST-ACUTE COVID-19 SYNDROME |
28 |
0.0226 |
| 63 |
INFUSION SITE EXTRAVASATION |
136 |
0.0218 |
| 64 |
MONOCYTE PERCENTAGE DECREASED |
4 |
0.0217 |
| 65 |
RECALLED PRODUCT |
37 |
0.0214 |
| 66 |
AMOEBIASIS |
5 |
0.0213 |
| 67 |
JEJUNAL PERFORATION |
5 |
0.0207 |
| 68 |
PULMONARY CAVITATION |
18 |
0.0207 |
| 69 |
PNEUMOTHORAX SPONTANEOUS |
14 |
0.0206 |
| 70 |
VACCINATION FAILURE |
34 |
0.0204 |
| 71 |
CRYPTOCOCCOSIS |
33 |
0.0202 |
| 72 |
EOSINOPHIL PERCENTAGE DECREASED |
4 |
0.0201 |
| 73 |
DIFFUSE ALVEOLAR DAMAGE |
23 |
0.0200 |
| 74 |
CARDIAC ASTHMA |
3 |
0.0200 |
| 75 |
PNEUMONIA STAPHYLOCOCCAL |
39 |
0.0197 |
| 76 |
LIVER FUNCTION TEST INCREASED |
422 |
0.0196 |
| 77 |
VACCINE INTERACTION |
6 |
0.0194 |
| 78 |
GEOTRICHUM INFECTION |
4 |
0.0190 |
| 79 |
BACTERIAL ENDOPHTHALMITIS |
5 |
0.0188 |
| 80 |
STENOTROPHOMONAS INFECTION |
25 |
0.0184 |
| 81 |
PULMONARY NOCARDIOSIS |
15 |
0.0182 |
| 82 |
FUNGAEMIA |
28 |
0.0178 |
| 83 |
HAEMOPERITONEUM |
14 |
0.0175 |
| 84 |
PULSELESS ELECTRICAL ACTIVITY |
73 |
0.0175 |
| 85 |
APGAR SCORE LOW |
22 |
0.0171 |
| 86 |
PNEUMONIA NECROTISING |
11 |
0.0170 |
| 87 |
PNEUMONIA PSEUDOMONAL |
26 |
0.0169 |
| 88 |
CORYNEBACTERIUM INFECTION |
9 |
0.0168 |
| 89 |
CANDIDA TEST POSITIVE |
7 |
0.0167 |
| 90 |
PURPURA FULMINANS |
4 |
0.0157 |
| 91 |
RETROPERITONEAL HAEMATOMA |
34 |
0.0154 |
| 92 |
ALANINE AMINOTRANSFERASE INCREASED |
935 |
0.0152 |
| 93 |
PRIMARY BILIARY CHOLANGITIS |
7 |
0.0149 |
| 94 |
SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA |
12 |
0.0146 |
| 95 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
11 |
0.0143 |
| 96 |
MECHANICAL VENTILATION |
27 |
0.0142 |
| 97 |
CEREBRAL FUNGAL INFECTION |
4 |
0.0141 |
| 98 |
BURKHOLDERIA CEPACIA COMPLEX INFECTION |
4 |
0.0140 |
| 99 |
PERIOSTITIS |
6 |
0.0139 |
| 100 |
VASOGENIC CEREBRAL OEDEMA |
10 |
0.0139 |
| 101 |
PNEUMONIA BACTERIAL |
124 |
0.0135 |
| 102 |
SINUS BRADYCARDIA |
129 |
0.0133 |
| 103 |
FUNGAL ENDOCARDITIS |
4 |
0.0133 |
| 104 |
HUMAN HERPESVIRUS 8 INFECTION |
8 |
0.0131 |
| 105 |
ASPERGILLUS INFECTION |
86 |
0.0131 |
| 106 |
CEREBRAL ASPERGILLOSIS |
8 |
0.0130 |
| 107 |
FIBRIN D DIMER INCREASED |
45 |
0.0126 |
| 108 |
TRANSIENT TACHYPNOEA OF THE NEWBORN |
5 |
0.0126 |
| 109 |
SARS-COV-2 ANTIBODY TEST NEGATIVE |
6 |
0.0125 |
| 110 |
PALLIATIVE CARE |
19 |
0.0124 |
| 111 |
PNEUMONIA CYTOMEGALOVIRAL |
24 |
0.0123 |
| 112 |
SPUTUM CULTURE POSITIVE |
10 |
0.0123 |
| 113 |
SPLENIC ABSCESS |
5 |
0.0123 |
| 114 |
BRADYCARDIA |
652 |
0.0123 |
| 115 |
ALLERGIC RESPIRATORY SYMPTOM |
4 |
0.0120 |
| 116 |
EXTRAVASATION |
49 |
0.0119 |
| 117 |
ASPARTATE AMINOTRANSFERASE INCREASED |
629 |
0.0118 |
| 118 |
PNEUMOCOCCAL INFECTION |
7 |
0.0118 |
| 119 |
RETROPERITONEAL HAEMORRHAGE |
29 |
0.0117 |
| 120 |
PROPOFOL INFUSION SYNDROME |
8 |
0.0113 |
| 121 |
MUSCLE ABSCESS |
7 |
0.0112 |
| 122 |
BONE INFARCTION |
5 |
0.0110 |
| 123 |
INTERLEUKIN LEVEL INCREASED |
6 |
0.0109 |
| 124 |
HAEMATOMA MUSCLE |
13 |
0.0108 |
| 125 |
INFUSION SITE OEDEMA |
9 |
0.0108 |
| 126 |
ENCEPHALOMALACIA |
6 |
0.0107 |
| 127 |
INTENSIVE CARE UNIT ACQUIRED WEAKNESS |
4 |
0.0105 |
| 128 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
186 |
0.0105 |
| 129 |
INFECTIOUS PLEURAL EFFUSION |
16 |
0.0105 |
| 130 |
HYPERBILIRUBINAEMIA NEONATAL |
6 |
0.0103 |
| 131 |
INTRAVENTRICULAR HAEMORRHAGE NEONATAL |
5 |
0.0103 |
| 132 |
CARDIAC VALVE VEGETATION |
5 |
0.0103 |
| 133 |
HYPERTRANSAMINASAEMIA |
71 |
0.0102 |
| 134 |
HAEMOPHILUS INFECTION |
10 |
0.0102 |
| 135 |
BLOOD FIBRINOGEN INCREASED |
8 |
0.0101 |
| 136 |
RENAL TRANSPLANT FAILURE |
10 |
0.0101 |
| 137 |
NECROTISING OESOPHAGITIS |
5 |
0.0100 |
| 138 |
TRICHOSPORON INFECTION |
4 |
0.0099 |
| 139 |
OPPORTUNISTIC INFECTION |
18 |
0.0097 |
| 140 |
GLOMERULAR FILTRATION RATE INCREASED |
8 |
0.0097 |
| 141 |
AMNIOTIC CAVITY INFECTION |
7 |
0.0097 |
| 142 |
GLOMERULAR FILTRATION RATE DECREASED |
117 |
0.0095 |
| 143 |
CREATININE RENAL CLEARANCE INCREASED |
7 |
0.0094 |
| 144 |
CHORIORETINITIS |
6 |
0.0093 |
| 145 |
ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC |
7 |
0.0093 |
| 146 |
KLEBSIELLA INFECTION |
47 |
0.0093 |
| 147 |
BLOOD GASES ABNORMAL |
5 |
0.0093 |
| 148 |
CONTINUOUS HAEMODIAFILTRATION |
9 |
0.0092 |
| 149 |
SYSTEMIC CANDIDA |
23 |
0.0092 |
| 150 |
ADMINISTRATION SITE EXTRAVASATION |
9 |
0.0090 |
| 151 |
RENAL INFARCT |
13 |
0.0090 |
| 152 |
REFUSAL OF TREATMENT BY RELATIVE |
4 |
0.0088 |
| 153 |
PELVIC ABSCESS |
10 |
0.0087 |
| 154 |
ENTEROCOCCAL INFECTION |
42 |
0.0087 |
| 155 |
INFANTILE APNOEA |
7 |
0.0086 |
| 156 |
ACUTE RESPIRATORY FAILURE |
165 |
0.0086 |
| 157 |
PROCALCITONIN INCREASED |
10 |
0.0085 |
| 158 |
NEONATAL RESPIRATORY DISTRESS |
8 |
0.0085 |
| 159 |
ORGANISING PNEUMONIA |
42 |
0.0085 |
| 160 |
PNEUMOTHORAX |
134 |
0.0084 |
| 161 |
BRADYCARDIA FOETAL |
7 |
0.0084 |
| 162 |
ENTEROBACTER INFECTION |
14 |
0.0083 |
| 163 |
CREATININE RENAL CLEARANCE DECREASED |
33 |
0.0082 |
| 164 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
233 |
0.0082 |
| 165 |
PNEUMONIA KLEBSIELLA |
15 |
0.0082 |
| 166 |
TRANSAMINASES INCREASED |
178 |
0.0080 |
| 167 |
NECROTISING RETINITIS |
5 |
0.0078 |
| 168 |
BLOOD MAGNESIUM INCREASED |
7 |
0.0078 |
| 169 |
SINUS ARREST |
12 |
0.0076 |
| 170 |
LUNG ABSCESS |
16 |
0.0076 |
| 171 |
PREMATURE DELIVERY |
121 |
0.0076 |
| 172 |
RESPIRATORY FAILURE |
552 |
0.0076 |
| 173 |
HYPOXIA |
261 |
0.0074 |
| 174 |
CENTRAL SEROUS CHORIORETINOPATHY |
5 |
0.0073 |
| 175 |
PNEUMONIA STREPTOCOCCAL |
8 |
0.0073 |
| 176 |
MARASMUS |
11 |
0.0072 |
| 177 |
PNEUMONIA VIRAL |
23 |
0.0072 |
| 178 |
FOETAL HEART RATE DECELERATION ABNORMALITY |
5 |
0.0071 |
| 179 |
SHOCK HAEMORRHAGIC |
57 |
0.0070 |
| 180 |
LEGIONELLA INFECTION |
4 |
0.0070 |
| 181 |
OPHTHALMIC HERPES SIMPLEX |
4 |
0.0069 |
| 182 |
LUNG OPACITY |
18 |
0.0068 |
| 183 |
SARS-COV-2 TEST POSITIVE |
90 |
0.0068 |
| 184 |
ENDOTRACHEAL INTUBATION |
19 |
0.0068 |
| 185 |
PNEUMOCYSTIS JIROVECII INFECTION |
8 |
0.0067 |
| 186 |
ABDOMINAL WALL HAEMATOMA |
13 |
0.0067 |
| 187 |
VIRAL MUTATION IDENTIFIED |
24 |
0.0065 |
| 188 |
TRACHEOBRONCHITIS |
5 |
0.0065 |
| 189 |
RECALLED PRODUCT ADMINISTERED |
62 |
0.0065 |
| 190 |
CRITICAL ILLNESS |
5 |
0.0064 |
| 191 |
MICROANGIOPATHY |
6 |
0.0064 |
| 192 |
SEPTIC SHOCK |
277 |
0.0064 |
| 193 |
HAEMODIALYSIS |
53 |
0.0063 |
| 194 |
OXYGEN CONSUMPTION INCREASED |
15 |
0.0063 |
| 195 |
BRONCHOPULMONARY DYSPLASIA |
5 |
0.0062 |
| 196 |
STAPHYLOCOCCAL BACTERAEMIA |
27 |
0.0062 |
| 197 |
ENDOCARDITIS |
31 |
0.0060 |
| 198 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
327 |
0.0060 |
| 199 |
PNEUMOPERITONEUM |
11 |
0.0059 |
| 200 |
PRODUCT PREPARATION ISSUE |
39 |
0.0059 |
| 201 |
HEPATITIS B DNA INCREASED |
4 |
0.0059 |
| 202 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
21 |
0.0059 |
| 203 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
18 |
0.0059 |
| 204 |
ABSCESS NECK |
4 |
0.0059 |
| 205 |
PULSE ABSENT |
28 |
0.0059 |
| 206 |
COCCIDIOIDOMYCOSIS |
7 |
0.0059 |
| 207 |
TRANSCRIPTION MEDICATION ERROR |
9 |
0.0057 |
| 208 |
SPLENIC INFARCTION |
10 |
0.0057 |
| 209 |
MENINGITIS CRYPTOCOCCAL |
10 |
0.0057 |
| 210 |
HISTOPLASMOSIS DISSEMINATED |
9 |
0.0057 |
| 211 |
ENTEROCOCCAL BACTERAEMIA |
6 |
0.0057 |
| 212 |
HYPERLEUKOCYTOSIS |
5 |
0.0056 |
| 213 |
INFLAMMATORY MARKER INCREASED |
28 |
0.0056 |
| 214 |
STRONGYLOIDIASIS |
9 |
0.0056 |
| 215 |
DISSEMINATED INTRAVASCULAR COAGULATION |
78 |
0.0055 |
| 216 |
LISTERIOSIS |
6 |
0.0054 |
| 217 |
EPSTEIN-BARR VIRAEMIA |
6 |
0.0054 |
| 218 |
PNEUMONIA PNEUMOCOCCAL |
8 |
0.0054 |
| 219 |
HYPERTHERMIA MALIGNANT |
8 |
0.0054 |
| 220 |
BRAIN STEM SYNDROME |
4 |
0.0053 |
| 221 |
STEROID DIABETES |
8 |
0.0053 |
| 222 |
KLEBSIELLA BACTERAEMIA |
5 |
0.0053 |
| 223 |
COVID-19 |
919 |
0.0052 |
| 224 |
CEREBRAL VENTRICLE DILATATION |
6 |
0.0052 |
| 225 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
39 |
0.0052 |
| 226 |
FOETAL DISTRESS SYNDROME |
11 |
0.0052 |
| 227 |
METHAEMOGLOBINAEMIA |
12 |
0.0052 |
| 228 |
TORSADE DE POINTES |
40 |
0.0051 |
| 229 |
ENDOCARDITIS BACTERIAL |
4 |
0.0051 |
| 230 |
PRINZMETAL ANGINA |
5 |
0.0050 |
| 231 |
EMPYEMA |
10 |
0.0050 |
| 232 |
DISEASE COMPLICATION |
23 |
0.0050 |
| 233 |
HYPOVOLAEMIC SHOCK |
24 |
0.0050 |
| 234 |
HAEMODYNAMIC INSTABILITY |
38 |
0.0050 |
| 235 |
HYPERCAPNIA |
15 |
0.0050 |
| 236 |
CHRONIC RESPIRATORY FAILURE |
6 |
0.0050 |
| 237 |
BLOOD CREATINE INCREASED |
22 |
0.0050 |
| 238 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
13 |
0.0050 |
| 239 |
BLOOD CREATININE INCREASED |
323 |
0.0049 |
| 240 |
CHORIORETINOPATHY |
7 |
0.0049 |
| 241 |
SINUS NODE DYSFUNCTION |
9 |
0.0049 |
| 242 |
PNEUMATOSIS INTESTINALIS |
14 |
0.0049 |
| 243 |
LOW BIRTH WEIGHT BABY |
39 |
0.0049 |
| 244 |
RENAL ABSCESS |
4 |
0.0049 |
| 245 |
VASOPLEGIA SYNDROME |
8 |
0.0049 |
| 246 |
OXYGEN THERAPY |
8 |
0.0049 |
| 247 |
CORONAVIRUS TEST POSITIVE |
5 |
0.0049 |
| 248 |
BLOOD LOSS ANAEMIA |
11 |
0.0049 |
| 249 |
NEONATAL HYPOXIA |
4 |
0.0048 |
| 250 |
NORMOCYTIC ANAEMIA |
7 |
0.0048 |
| 251 |
WHITE MATTER LESION |
6 |
0.0047 |
| 252 |
CEREBRAL VENOUS SINUS THROMBOSIS |
4 |
0.0047 |
| 253 |
ORGAN FAILURE |
19 |
0.0047 |
| 254 |
PSEUDOMONAL BACTERAEMIA |
4 |
0.0047 |
| 255 |
IMMUNOSUPPRESSION |
41 |
0.0046 |
| 256 |
URINARY TRACT OBSTRUCTION |
11 |
0.0046 |
| 257 |
DRUG CLEARANCE DECREASED |
6 |
0.0046 |
| 258 |
PNEUMONIA FUNGAL |
18 |
0.0046 |
| 259 |
B-LYMPHOCYTE COUNT DECREASED |
6 |
0.0044 |
| 260 |
ACIDOSIS |
33 |
0.0043 |
| 261 |
ANGLE CLOSURE GLAUCOMA |
11 |
0.0043 |
| 262 |
CYTOMEGALOVIRUS VIRAEMIA |
19 |
0.0043 |
| 263 |
SHOCK |
97 |
0.0042 |
| 264 |
HYPERNATRAEMIA |
21 |
0.0042 |
| 265 |
CATATONIA |
22 |
0.0042 |
| 266 |
ALANINE AMINOTRANSFERASE DECREASED |
3 |
0.0041 |
| 267 |
ACUTE KIDNEY INJURY |
630 |
0.0041 |
| 268 |
RESPIRATORY ACIDOSIS |
16 |
0.0041 |
| 269 |
MULTI-ORGAN DISORDER |
8 |
0.0041 |
| 270 |
LARGE INTESTINAL ULCER |
11 |
0.0040 |
| 271 |
BACTERAEMIA |
48 |
0.0040 |
| 272 |
HEPATITIS FULMINANT |
12 |
0.0040 |
| 273 |
PUPIL FIXED |
7 |
0.0040 |
| 274 |
PRODUCT PREPARATION ERROR |
83 |
0.0040 |
| 275 |
GASTROINTESTINAL WALL THICKENING |
6 |
0.0040 |
| 276 |
PSEUDOMONAL SEPSIS |
7 |
0.0040 |
| 277 |
THERAPY CESSATION |
205 |
0.0040 |
| 278 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
40 |
0.0040 |
| 279 |
RENAL TUBULAR NECROSIS |
39 |
0.0040 |
| 280 |
PSEUDOMONAS INFECTION |
34 |
0.0040 |
| 281 |
TRANSPLANT DYSFUNCTION |
7 |
0.0039 |
| 282 |
PANCREATITIS NECROTISING |
9 |
0.0039 |
| 283 |
ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC |
6 |
0.0039 |
| 284 |
COUNTERFEIT PRODUCT ADMINISTERED |
5 |
0.0038 |
| 285 |
ENTHESOPATHY |
6 |
0.0038 |
| 286 |
LATENT TUBERCULOSIS |
8 |
0.0038 |
| 287 |
PULMONARY INFARCTION |
9 |
0.0038 |
| 288 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
5 |
0.0038 |
| 289 |
STAPHYLOCOCCUS TEST POSITIVE |
8 |
0.0038 |
| 290 |
INTRA-ABDOMINAL HAEMORRHAGE |
9 |
0.0038 |
| 291 |
TACHYPNOEA |
51 |
0.0037 |
| 292 |
CEREBRAL ARTERY OCCLUSION |
4 |
0.0037 |
| 293 |
GALLBLADDER ENLARGEMENT |
4 |
0.0037 |
| 294 |
TOXOPLASMOSIS |
4 |
0.0037 |
| 295 |
BLOOD SODIUM INCREASED |
10 |
0.0037 |
| 296 |
OXYGEN SATURATION DECREASED |
208 |
0.0037 |
| 297 |
RESPIRATORY ALKALOSIS |
6 |
0.0037 |
| 298 |
GASTRIC PERFORATION |
10 |
0.0037 |
| 299 |
FOETAL DEATH |
19 |
0.0037 |
| 300 |
ACINETOBACTER INFECTION |
4 |
0.0037 |
| 301 |
PREMATURE BABY |
109 |
0.0036 |
| 302 |
BRAIN DEATH |
11 |
0.0036 |
| 303 |
HYPOGAMMAGLOBULINAEMIA |
23 |
0.0035 |
| 304 |
CARBON DIOXIDE DECREASED |
4 |
0.0035 |
| 305 |
CARDIAC ARREST |
286 |
0.0035 |
| 306 |
CYTOMEGALOVIRUS TEST POSITIVE |
6 |
0.0034 |
| 307 |
RENAL IMPAIRMENT |
282 |
0.0034 |
| 308 |
PRODUCT CONTAMINATION MICROBIAL |
4 |
0.0034 |
| 309 |
LIVEDO RETICULARIS |
7 |
0.0033 |
| 310 |
CANDIDA SEPSIS |
3 |
0.0033 |
| 311 |
PROTHROMBIN TIME PROLONGED |
20 |
0.0033 |
| 312 |
INFUSION SITE SWELLING |
21 |
0.0033 |
| 313 |
SUPERINFECTION |
5 |
0.0033 |
| 314 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
11 |
0.0033 |
| 315 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
11 |
0.0033 |
| 316 |
ALANINE AMINOTRANSFERASE ABNORMAL |
7 |
0.0033 |
| 317 |
HEPATOCELLULAR INJURY |
47 |
0.0033 |
| 318 |
INTERNATIONAL NORMALISED RATIO INCREASED |
94 |
0.0033 |
| 319 |
CANDIDA INFECTION |
55 |
0.0033 |
| 320 |
EMBOLISM |
27 |
0.0032 |
| 321 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
16 |
0.0032 |
| 322 |
SUPRAVENTRICULAR TACHYCARDIA |
31 |
0.0032 |
| 323 |
OXYGEN SATURATION ABNORMAL |
9 |
0.0032 |
| 324 |
GASTRIC ULCER PERFORATION |
4 |
0.0032 |
| 325 |
PULMONARY TUBERCULOSIS |
13 |
0.0030 |
| 326 |
INTERCEPTED PRODUCT DISPENSING ERROR |
5 |
0.0030 |
| 327 |
LIVER INJURY |
74 |
0.0030 |
| 328 |
BLOOD CULTURE POSITIVE |
9 |
0.0030 |
| 329 |
METABOLIC ENCEPHALOPATHY |
9 |
0.0030 |
| 330 |
LEUKOCYTOSIS |
54 |
0.0030 |
| 331 |
PNEUMONIA ASPIRATION |
74 |
0.0030 |
| 332 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
23 |
0.0030 |
| 333 |
ELECTROCARDIOGRAM QT PROLONGED |
106 |
0.0029 |
| 334 |
HERPES SIMPLEX |
19 |
0.0029 |
| 335 |
HEPATIC FUNCTION ABNORMAL |
109 |
0.0029 |
| 336 |
ESCHERICHIA INFECTION |
24 |
0.0029 |
| 337 |
DIVERTICULAR PERFORATION |
6 |
0.0029 |
| 338 |
OLIGURIA |
18 |
0.0029 |
| 339 |
DIALYSIS |
41 |
0.0029 |
| 340 |
DEATH NEONATAL |
4 |
0.0029 |
| 341 |
ACUTE HEPATIC FAILURE |
39 |
0.0029 |
| 342 |
PERIPHERAL ARTERY OCCLUSION |
4 |
0.0028 |
| 343 |
GLOMERULAR FILTRATION RATE ABNORMAL |
4 |
0.0028 |
| 344 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
70 |
0.0028 |
| 345 |
MENINGITIS BACTERIAL |
4 |
0.0028 |
| 346 |
HYPERPHOSPHATAEMIA |
6 |
0.0028 |
| 347 |
BACTERIAL SEPSIS |
9 |
0.0028 |
| 348 |
HYPERSEXUALITY |
5 |
0.0027 |
| 349 |
LARGE INTESTINE PERFORATION |
19 |
0.0027 |
| 350 |
MYASTHENIA GRAVIS CRISIS |
4 |
0.0027 |
| 351 |
RESPIRATORY DISTRESS |
74 |
0.0027 |
| 352 |
INFUSION SITE REACTION |
8 |
0.0027 |
| 353 |
ENDOPHTHALMITIS |
16 |
0.0027 |
| 354 |
STAPHYLOCOCCAL SEPSIS |
13 |
0.0026 |
| 355 |
PATHOGEN RESISTANCE |
24 |
0.0026 |
| 356 |
BLOOD BILIRUBIN INCREASED |
71 |
0.0026 |
| 357 |
PREMATURE SEPARATION OF PLACENTA |
4 |
0.0026 |
| 358 |
AORTIC VALVE INCOMPETENCE |
11 |
0.0026 |
| 359 |
COAGULOPATHY |
43 |
0.0026 |
| 360 |
BILIRUBIN CONJUGATED INCREASED |
6 |
0.0026 |
| 361 |
OFF LABEL USE |
2245 |
0.0026 |
| 362 |
MEGACOLON |
4 |
0.0025 |
| 363 |
PATENT DUCTUS ARTERIOSUS |
10 |
0.0025 |
| 364 |
DRUG-INDUCED LIVER INJURY |
79 |
0.0025 |
| 365 |
HEPATOTOXICITY |
56 |
0.0025 |
| 366 |
PULMONARY FUNCTION TEST DECREASED |
11 |
0.0025 |
| 367 |
HEPATIC CYTOLYSIS |
32 |
0.0025 |
| 368 |
TROPONIN INCREASED |
19 |
0.0025 |
| 369 |
ANTIPHOSPHOLIPID SYNDROME |
4 |
0.0025 |
| 370 |
GUILLAIN-BARRE SYNDROME |
12 |
0.0025 |
| 371 |
CEREBRAL ARTERY EMBOLISM |
3 |
0.0025 |
| 372 |
HAEMATOLOGICAL INFECTION |
6 |
0.0025 |
| 373 |
BLOOD UREA INCREASED |
41 |
0.0024 |
| 374 |
MATERNAL EXPOSURE DURING PREGNANCY |
217 |
0.0024 |
| 375 |
VENTRICULAR TACHYCARDIA |
40 |
0.0024 |
| 376 |
HEART RATE DECREASED |
84 |
0.0024 |
| 377 |
ATRIOVENTRICULAR BLOCK COMPLETE |
16 |
0.0024 |
| 378 |
LUNG INFILTRATION |
21 |
0.0024 |
| 379 |
GASTRITIS EROSIVE |
11 |
0.0024 |
| 380 |
INFUSION SITE BRUISING |
5 |
0.0023 |
| 381 |
PULMONARY HAEMORRHAGE |
18 |
0.0023 |
| 382 |
CYTOMEGALOVIRUS INFECTION |
38 |
0.0023 |
| 383 |
RESPIRATORY DISORDER |
68 |
0.0023 |
| 384 |
NOSOCOMIAL INFECTION |
5 |
0.0023 |
| 385 |
NECROTISING FASCIITIS |
8 |
0.0023 |
| 386 |
VENTRICULAR FIBRILLATION |
25 |
0.0022 |
| 387 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
5 |
0.0022 |
| 388 |
IRON DEFICIENCY |
10 |
0.0022 |
| 389 |
KOUNIS SYNDROME |
5 |
0.0022 |
| 390 |
METABOLIC ACIDOSIS |
70 |
0.0022 |
| 391 |
THROMBOCYTOSIS |
8 |
0.0022 |
| 392 |
EUGLYCAEMIC DIABETIC KETOACIDOSIS |
9 |
0.0022 |
| 393 |
INTESTINAL ISCHAEMIA |
12 |
0.0022 |
| 394 |
HEPATIC ENZYME INCREASED |
148 |
0.0022 |
| 395 |
STAPHYLOCOCCAL INFECTION |
71 |
0.0022 |
| 396 |
CARDIO-RESPIRATORY ARREST |
90 |
0.0022 |
| 397 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
34 |
0.0021 |
| 398 |
REFUSAL OF TREATMENT BY PATIENT |
14 |
0.0021 |
| 399 |
INFUSION SITE ERYTHEMA |
18 |
0.0021 |
| 400 |
JAUNDICE NEONATAL |
4 |
0.0021 |
| 401 |
EXPOSURE DURING PREGNANCY |
131 |
0.0021 |
| 402 |
PRE-ECLAMPSIA |
10 |
0.0021 |
| 403 |
HYPERGLYCAEMIA |
76 |
0.0021 |
| 404 |
SERUM FERRITIN INCREASED |
11 |
0.0021 |
| 405 |
ADRENAL DISORDER |
4 |
0.0021 |
| 406 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
9 |
0.0020 |
| 407 |
HYPERBILIRUBINAEMIA |
21 |
0.0020 |
| 408 |
CATHETER SITE HAEMORRHAGE |
5 |
0.0020 |
| 409 |
EMBOLISM VENOUS |
6 |
0.0020 |
| 410 |
BRAIN ABSCESS |
5 |
0.0020 |
| 411 |
CORONAVIRUS INFECTION |
13 |
0.0020 |
| 412 |
PERIPHERAL ISCHAEMIA |
8 |
0.0020 |
| 413 |
CHEST X-RAY ABNORMAL |
6 |
0.0020 |
| 414 |
ACUTE MYOCARDIAL INFARCTION |
56 |
0.0019 |
| 415 |
BLOOD LACTIC ACID INCREASED |
10 |
0.0019 |
| 416 |
AMYLASE INCREASED |
7 |
0.0019 |
| 417 |
HEPATIC FAILURE |
57 |
0.0019 |
| 418 |
CARDIAC DYSFUNCTION |
7 |
0.0019 |
| 419 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
5 |
0.0019 |
| 420 |
CHOLESTASIS |
36 |
0.0019 |
| 421 |
INTESTINAL PERFORATION |
21 |
0.0019 |
| 422 |
INFUSION RELATED REACTION |
124 |
0.0019 |
| 423 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
4 |
0.0019 |
| 424 |
HYPERKALAEMIA |
65 |
0.0019 |
| 425 |
CARDIOVASCULAR INSUFFICIENCY |
3 |
0.0018 |
| 426 |
LYMPHOPENIA |
26 |
0.0018 |
| 427 |
ENCEPHALOPATHY |
45 |
0.0018 |
| 428 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
7 |
0.0018 |
| 429 |
BRADYARRHYTHMIA |
3 |
0.0018 |
| 430 |
GRAFT VERSUS HOST DISEASE IN SKIN |
4 |
0.0018 |
| 431 |
DRUG LEVEL INCREASED |
30 |
0.0018 |
| 432 |
LYMPHOCYTE COUNT DECREASED |
32 |
0.0018 |
| 433 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
9 |
0.0018 |
| 434 |
TEMPERATURE REGULATION DISORDER |
4 |
0.0018 |
| 435 |
CARDIOPULMONARY FAILURE |
7 |
0.0018 |
| 436 |
LUNG CONSOLIDATION |
5 |
0.0018 |
| 437 |
PANCREATITIS ACUTE |
40 |
0.0018 |
| 438 |
FOETAL EXPOSURE DURING PREGNANCY |
144 |
0.0018 |
| 439 |
CHOLECYSTITIS ACUTE |
10 |
0.0018 |
| 440 |
AMMONIA INCREASED |
9 |
0.0018 |
| 441 |
ECCHYMOSIS |
12 |
0.0017 |
| 442 |
CYTOKINE RELEASE SYNDROME |
35 |
0.0017 |
| 443 |
CYTOMEGALOVIRUS COLITIS |
4 |
0.0017 |
| 444 |
BLOOD CHLORIDE INCREASED |
3 |
0.0017 |
| 445 |
CAROTID ARTERY STENOSIS |
6 |
0.0017 |
| 446 |
THERAPY NON-RESPONDER |
77 |
0.0017 |
| 447 |
HYPERTRIGLYCERIDAEMIA |
10 |
0.0017 |
| 448 |
HYPERTENSIVE CRISIS |
19 |
0.0017 |
| 449 |
INJECTION SITE EXTRAVASATION |
21 |
0.0017 |
| 450 |
BRAIN HERNIATION |
5 |
0.0017 |
| 451 |
LIVE BIRTH |
14 |
0.0017 |
| 452 |
KIDNEY TRANSPLANT REJECTION |
8 |
0.0017 |
| 453 |
HALLUCINATIONS, MIXED |
7 |
0.0017 |
| 454 |
DIABETES INSIPIDUS |
4 |
0.0017 |
| 455 |
NORMAL NEWBORN |
9 |
0.0017 |
| 456 |
ADRENAL INSUFFICIENCY |
20 |
0.0016 |
| 457 |
THROMBOTIC MICROANGIOPATHY |
16 |
0.0016 |
| 458 |
SEPSIS |
181 |
0.0016 |
| 459 |
BLOOD IMMUNOGLOBULIN G DECREASED |
4 |
0.0016 |
| 460 |
URINE OUTPUT DECREASED |
14 |
0.0016 |
| 461 |
EPSTEIN-BARR VIRUS INFECTION |
10 |
0.0016 |
| 462 |
STATUS EPILEPTICUS |
18 |
0.0016 |
| 463 |
BLOOD BICARBONATE DECREASED |
3 |
0.0016 |
| 464 |
HYPOTHERMIA |
16 |
0.0016 |
| 465 |
DERMATOMYOSITIS |
4 |
0.0016 |
| 466 |
PRODUCT CONTAMINATION PHYSICAL |
4 |
0.0016 |
| 467 |
NOCARDIOSIS |
4 |
0.0016 |
| 468 |
ARTERIAL THROMBOSIS |
3 |
0.0016 |
| 469 |
UNRESPONSIVE TO STIMULI |
40 |
0.0015 |
| 470 |
SUSPECTED OFF LABEL USE |
7 |
0.0015 |
| 471 |
VASCULAR DEVICE INFECTION |
7 |
0.0015 |
| 472 |
RHINOVIRUS INFECTION |
6 |
0.0015 |
| 473 |
HEPATITIS TOXIC |
4 |
0.0015 |
| 474 |
CARDIOGENIC SHOCK |
22 |
0.0015 |
| 475 |
THROMBOSIS IN DEVICE |
5 |
0.0015 |
| 476 |
ALTERED STATE OF CONSCIOUSNESS |
33 |
0.0015 |
| 477 |
HOSPICE CARE |
15 |
0.0015 |
| 478 |
BLOOD ALBUMIN DECREASED |
12 |
0.0015 |
| 479 |
ANURIA |
13 |
0.0015 |
| 480 |
AZOTAEMIA |
6 |
0.0015 |
| 481 |
AREFLEXIA |
4 |
0.0015 |
| 482 |
SUPRAVENTRICULAR EXTRASYSTOLES |
5 |
0.0015 |
| 483 |
FOETAL GROWTH RESTRICTION |
9 |
0.0015 |
| 484 |
CARDIAC TAMPONADE |
7 |
0.0015 |
| 485 |
BLOOD PHOSPHORUS INCREASED |
4 |
0.0015 |
| 486 |
ARTHRITIS BACTERIAL |
6 |
0.0015 |
| 487 |
ORAL FUNGAL INFECTION |
4 |
0.0015 |
| 488 |
CAESAREAN SECTION |
17 |
0.0015 |
| 489 |
LEUKOPENIA |
73 |
0.0015 |
| 490 |
CAPILLARY LEAK SYNDROME |
3 |
0.0014 |
| 491 |
PRIAPISM |
5 |
0.0014 |
| 492 |
ATELECTASIS |
14 |
0.0014 |
| 493 |
BACTERIAL INFECTION |
27 |
0.0014 |
| 494 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
32 |
0.0014 |
| 495 |
DRUG RESISTANCE |
37 |
0.0014 |
| 496 |
STREPTOCOCCAL INFECTION |
8 |
0.0014 |
| 497 |
THERAPY INTERRUPTED |
102 |
0.0014 |
| 498 |
ACUTE PULMONARY OEDEMA |
8 |
0.0014 |
| 499 |
ATRIOVENTRICULAR BLOCK |
11 |
0.0014 |
| 500 |
DRUG INTERACTION |
225 |
0.0014 |
| 501 |
FACIAL PARESIS |
5 |
0.0014 |
| 502 |
ESCHERICHIA URINARY TRACT INFECTION |
6 |
0.0014 |
| 503 |
HYPOTENSION |
283 |
0.0014 |
| 504 |
HEART VALVE INCOMPETENCE |
4 |
0.0014 |
| 505 |
PRODUCT ADMINISTRATION ERROR |
28 |
0.0014 |
| 506 |
HAEMOTHORAX |
4 |
0.0014 |
| 507 |
RESPIRATORY ARREST |
38 |
0.0014 |
| 508 |
SUBARACHNOID HAEMORRHAGE |
14 |
0.0014 |
| 509 |
GASTROINTESTINAL NECROSIS |
4 |
0.0014 |
| 510 |
PULMONARY PAIN |
4 |
0.0014 |
| 511 |
HYPOVOLAEMIA |
8 |
0.0014 |
| 512 |
STRIDOR |
4 |
0.0014 |
| 513 |
HYPOPHOSPHATAEMIA |
10 |
0.0014 |
| 514 |
RESPIRATORY RATE INCREASED |
12 |
0.0014 |
| 515 |
PULMONARY EMBOLISM |
128 |
0.0013 |
| 516 |
BACTERIAL TEST POSITIVE |
3 |
0.0013 |
| 517 |
TRANSFUSION |
14 |
0.0013 |
| 518 |
BLOOD CALCIUM DECREASED |
15 |
0.0013 |
| 519 |
MENTAL STATUS CHANGES |
37 |
0.0013 |
| 520 |
LIVER DISORDER |
59 |
0.0013 |
| 521 |
DELIRIUM |
46 |
0.0013 |
| 522 |
BLOOD PRESSURE SYSTOLIC DECREASED |
6 |
0.0013 |
| 523 |
CONDITION AGGRAVATED |
396 |
0.0013 |
| 524 |
RENAL FUNCTION TEST ABNORMAL |
6 |
0.0013 |
| 525 |
CONTRAINDICATED PRODUCT ADMINISTERED |
39 |
0.0013 |
| 526 |
NEUROLEPTIC MALIGNANT SYNDROME |
15 |
0.0013 |
| 527 |
RENAL FAILURE |
167 |
0.0013 |
| 528 |
NEPHROPATHY TOXIC |
14 |
0.0012 |
| 529 |
REBOUND EFFECT |
14 |
0.0012 |
| 530 |
PREMATURE LABOUR |
7 |
0.0012 |
| 531 |
ATRIAL FIBRILLATION |
119 |
0.0012 |
| 532 |
RASH MACULO-PAPULAR |
27 |
0.0012 |
| 533 |
SUSPECTED COVID-19 |
4 |
0.0012 |
| 534 |
STRESS CARDIOMYOPATHY |
7 |
0.0012 |
| 535 |
PULMONARY FIBROSIS |
23 |
0.0012 |
| 536 |
INTENTIONAL PRODUCT USE ISSUE |
105 |
0.0012 |
| 537 |
SINUS TACHYCARDIA |
17 |
0.0012 |
| 538 |
CEREBRAL INFARCTION |
29 |
0.0012 |
| 539 |
DRUG ERUPTION |
21 |
0.0012 |
| 540 |
WRONG PRODUCT ADMINISTERED |
8 |
0.0012 |
| 541 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
6 |
0.0012 |
| 542 |
FAILURE TO THRIVE |
6 |
0.0012 |
| 543 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
5 |
0.0012 |
| 544 |
PARTIAL SEIZURES |
6 |
0.0011 |
| 545 |
ERYTHEMA NODOSUM |
4 |
0.0011 |
| 546 |
ORAL CANDIDIASIS |
15 |
0.0011 |
| 547 |
MELAENA |
25 |
0.0011 |
| 548 |
MYOCARDITIS |
13 |
0.0011 |
| 549 |
PULMONARY TOXICITY |
8 |
0.0011 |
| 550 |
LIVER FUNCTION TEST ABNORMAL |
32 |
0.0011 |
| 551 |
ASPIRATION |
12 |
0.0011 |
| 552 |
HEPATITIS |
28 |
0.0011 |
| 553 |
IMMUNE THROMBOCYTOPENIA |
5 |
0.0011 |
| 554 |
THERAPY PARTIAL RESPONDER |
17 |
0.0011 |
| 555 |
BUNDLE BRANCH BLOCK RIGHT |
5 |
0.0011 |
| 556 |
EOSINOPHIL COUNT INCREASED |
9 |
0.0011 |
| 557 |
IMMUNODEFICIENCY |
16 |
0.0011 |
| 558 |
PULMONARY ALVEOLAR HAEMORRHAGE |
6 |
0.0011 |
| 559 |
HYDRONEPHROSIS |
8 |
0.0011 |
| 560 |
PROTEIN TOTAL DECREASED |
4 |
0.0011 |
| 561 |
VENTRICULAR EXTRASYSTOLES |
11 |
0.0011 |
| 562 |
GENERAL PHYSICAL HEALTH DETERIORATION |
121 |
0.0010 |
| 563 |
LIPASE INCREASED |
8 |
0.0010 |
| 564 |
CLOSTRIDIUM DIFFICILE COLITIS |
11 |
0.0010 |
| 565 |
STILLBIRTH |
5 |
0.0010 |
| 566 |
PNEUMONIA |
334 |
0.0010 |
| 567 |
HYPOALBUMINAEMIA |
8 |
0.0010 |
| 568 |
ABORTION |
3 |
0.0010 |
| 569 |
CYANOSIS |
16 |
0.0010 |
| 570 |
PERITONITIS |
21 |
0.0010 |
| 571 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
6 |
0.0010 |
| 572 |
BIPOLAR DISORDER |
11 |
0.0010 |
| 573 |
CEREBRAL ATROPHY |
4 |
0.0010 |
| 574 |
PLATELET COUNT INCREASED |
13 |
0.0010 |
| 575 |
LACTIC ACIDOSIS |
32 |
0.0010 |
| 576 |
TOXIC EPIDERMAL NECROLYSIS |
15 |
0.0010 |
| 577 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
5 |
0.0010 |
| 578 |
DECUBITUS ULCER |
8 |
0.0010 |
| 579 |
DEMYELINATION |
4 |
0.0010 |
| 580 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
5 |
0.0010 |
| 581 |
THROMBOCYTOPENIA |
109 |
0.0010 |
| 582 |
TACHYCARDIA |
86 |
0.0010 |
| 583 |
HAEMATOMA |
25 |
0.0010 |
| 584 |
GASTROINTESTINAL PERFORATION |
4 |
0.0010 |
| 585 |
BLOOD CREATININE DECREASED |
3 |
0.0010 |
| 586 |
BRAIN OEDEMA |
12 |
0.0009 |
| 587 |
BLOOD PRESSURE DECREASED |
63 |
0.0009 |
| 588 |
INCORRECT DRUG ADMINISTRATION RATE |
4 |
0.0009 |
| 589 |
ABSCESS LIMB |
4 |
0.0009 |
| 590 |
CARDIAC FAILURE CHRONIC |
4 |
0.0009 |
| 591 |
WHITE BLOOD CELL COUNT INCREASED |
36 |
0.0009 |
| 592 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
27 |
0.0009 |
| 593 |
HYPOMAGNESAEMIA |
13 |
0.0009 |
| 594 |
INTERSTITIAL LUNG DISEASE |
45 |
0.0009 |
| 595 |
PYELONEPHRITIS |
8 |
0.0009 |
| 596 |
PULMONARY CONGESTION |
12 |
0.0009 |
| 597 |
ABDOMINAL ABSCESS |
4 |
0.0009 |
| 598 |
CARDIAC FAILURE ACUTE |
6 |
0.0009 |
| 599 |
APNOEA |
7 |
0.0009 |
| 600 |
ISCHAEMIC STROKE |
16 |
0.0009 |
| 601 |
HAEMOLYTIC ANAEMIA |
8 |
0.0009 |
| 602 |
PAPILLOEDEMA |
4 |
0.0009 |
| 603 |
DEATH |
762 |
0.0009 |
| 604 |
NO ADVERSE EVENT |
160 |
0.0009 |
| 605 |
ATRIAL FLUTTER |
7 |
0.0009 |
| 606 |
DRUG LEVEL ABOVE THERAPEUTIC |
4 |
0.0009 |
| 607 |
PRODUCT DISPENSING ERROR |
19 |
0.0009 |
| 608 |
ISCHAEMIA |
4 |
0.0009 |
| 609 |
PRODUCT USE IN UNAPPROVED INDICATION |
215 |
0.0009 |
| 610 |
UROSEPSIS |
8 |
0.0009 |
| 611 |
HAEMATOCRIT DECREASED |
17 |
0.0009 |
| 612 |
EJECTION FRACTION DECREASED |
13 |
0.0008 |
| 613 |
TUMOUR MARKER INCREASED |
4 |
0.0008 |
| 614 |
BODY TEMPERATURE INCREASED |
17 |
0.0008 |
| 615 |
PANCREATITIS |
44 |
0.0008 |
| 616 |
HEPATITIS CHOLESTATIC |
5 |
0.0008 |
| 617 |
GASTROINTESTINAL HAEMORRHAGE |
69 |
0.0008 |
| 618 |
CAROTID ARTERY OCCLUSION |
3 |
0.0008 |
| 619 |
DISEASE RECURRENCE |
39 |
0.0008 |
| 620 |
MYOPATHY |
7 |
0.0008 |
| 621 |
HYPERVOLAEMIA |
4 |
0.0008 |
| 622 |
CHOLANGITIS |
5 |
0.0008 |
| 623 |
SMALL FOR DATES BABY |
4 |
0.0008 |
| 624 |
DISEASE PROGRESSION |
95 |
0.0008 |
| 625 |
BLOOD POTASSIUM INCREASED |
13 |
0.0008 |
| 626 |
C-REACTIVE PROTEIN INCREASED |
29 |
0.0008 |
| 627 |
RHABDOMYOLYSIS |
33 |
0.0008 |
| 628 |
INFUSION SITE PAIN |
10 |
0.0008 |
| 629 |
ELECTROLYTE IMBALANCE |
9 |
0.0008 |
| 630 |
BENIGN PROSTATIC HYPERPLASIA |
4 |
0.0008 |
| 631 |
DEEP VEIN THROMBOSIS |
50 |
0.0008 |
| 632 |
HEPATITIS ACUTE |
5 |
0.0008 |
| 633 |
RETINAL DETACHMENT |
7 |
0.0008 |
| 634 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
30 |
0.0008 |
| 635 |
MENINGITIS |
5 |
0.0007 |
| 636 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
16 |
0.0007 |
| 637 |
PULMONARY THROMBOSIS |
8 |
0.0007 |
| 638 |
INFARCTION |
5 |
0.0007 |
| 639 |
PHARYNGEAL SWELLING |
7 |
0.0007 |
| 640 |
MALNUTRITION |
8 |
0.0007 |
| 641 |
PULMONARY OEDEMA |
32 |
0.0007 |
| 642 |
HEPATOMEGALY |
7 |
0.0007 |
| 643 |
BUNDLE BRANCH BLOCK LEFT |
3 |
0.0007 |
| 644 |
MITRAL VALVE INCOMPETENCE |
8 |
0.0007 |
| 645 |
BRONCHOSPASM |
10 |
0.0007 |
| 646 |
PARALYSIS |
10 |
0.0007 |
| 647 |
BRAIN INJURY |
7 |
0.0007 |
| 648 |
TOXIC SKIN ERUPTION |
7 |
0.0007 |
| 649 |
EMPHYSEMA |
7 |
0.0007 |
| 650 |
FLUID OVERLOAD |
10 |
0.0007 |
| 651 |
EOSINOPHILIA |
12 |
0.0007 |
| 652 |
NEUTROPHIL COUNT INCREASED |
7 |
0.0007 |
| 653 |
HAEMOPTYSIS |
19 |
0.0007 |
| 654 |
PRODUCT USE ISSUE |
128 |
0.0007 |
| 655 |
CARDIOTOXICITY |
6 |
0.0007 |
| 656 |
HEPATITIS B |
4 |
0.0007 |
| 657 |
PNEUMONITIS |
18 |
0.0007 |
| 658 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
11 |
0.0007 |
| 659 |
CIRCULATORY COLLAPSE |
11 |
0.0006 |
| 660 |
PARANOIA |
11 |
0.0006 |
| 661 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
16 |
0.0006 |
| 662 |
HEART RATE IRREGULAR |
14 |
0.0006 |
| 663 |
CARDIOMYOPATHY |
9 |
0.0006 |
| 664 |
BREATH SOUNDS ABNORMAL |
3 |
0.0006 |
| 665 |
MANIA |
10 |
0.0006 |
| 666 |
ABDOMINAL TENDERNESS |
3 |
0.0006 |
| 667 |
HEMIPLEGIA |
5 |
0.0006 |
| 668 |
FUNGAL INFECTION |
20 |
0.0006 |
| 669 |
AGITATION |
44 |
0.0006 |
| 670 |
CLOSTRIDIUM DIFFICILE INFECTION |
13 |
0.0006 |
| 671 |
RED BLOOD CELL COUNT DECREASED |
17 |
0.0006 |
| 672 |
PRODUCT LABEL ISSUE |
4 |
0.0006 |
| 673 |
NEUTROPHIL COUNT DECREASED |
24 |
0.0006 |
| 674 |
CHILLS |
69 |
0.0006 |
| 675 |
HYPERLIPIDAEMIA |
7 |
0.0006 |
| 676 |
POLYNEUROPATHY |
7 |
0.0006 |
| 677 |
HAEMOGLOBIN DECREASED |
60 |
0.0006 |
| 678 |
DRUG INEFFECTIVE |
768 |
0.0006 |
| 679 |
RESPIRATION ABNORMAL |
4 |
0.0006 |
| 680 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
5 |
0.0006 |
| 681 |
EXTRASYSTOLES |
4 |
0.0006 |
| 682 |
INTERCEPTED PRODUCT PREPARATION ERROR |
7 |
0.0006 |
| 683 |
HYPERCALCAEMIA |
7 |
0.0006 |
| 684 |
CEREBRAL HAEMORRHAGE |
20 |
0.0006 |
| 685 |
ANAL ABSCESS |
3 |
0.0006 |
| 686 |
MOUTH HAEMORRHAGE |
4 |
0.0005 |
| 687 |
HEPATIC STEATOSIS |
10 |
0.0005 |
| 688 |
PLATELET COUNT DECREASED |
57 |
0.0005 |
| 689 |
PYREXIA |
185 |
0.0005 |
| 690 |
LUNG DISORDER |
26 |
0.0005 |
| 691 |
COMA |
25 |
0.0005 |
| 692 |
CARDIAC FAILURE |
42 |
0.0005 |
| 693 |
DIFFUSE LARGE B-CELL LYMPHOMA |
4 |
0.0005 |
| 694 |
HAEMORRHAGIC STROKE |
4 |
0.0005 |
| 695 |
ELECTROCARDIOGRAM ABNORMAL |
4 |
0.0005 |
| 696 |
ANAPHYLACTIC SHOCK |
13 |
0.0005 |
| 697 |
CHOLECYSTITIS |
6 |
0.0005 |
| 698 |
BLOOD DISORDER |
4 |
0.0005 |
| 699 |
HYPOKALAEMIA |
23 |
0.0005 |
| 700 |
MYASTHENIA GRAVIS |
4 |
0.0005 |
| 701 |
PLEURAL EFFUSION |
30 |
0.0005 |
| 702 |
ASPHYXIA |
4 |
0.0005 |
| 703 |
HICCUPS |
4 |
0.0005 |
| 704 |
GENERALISED OEDEMA |
6 |
0.0005 |
| 705 |
AGRANULOCYTOSIS |
9 |
0.0005 |
| 706 |
ACUTE CORONARY SYNDROME |
4 |
0.0005 |
| 707 |
RASH ERYTHEMATOUS |
23 |
0.0005 |
| 708 |
NEUTROPENIA |
65 |
0.0005 |
| 709 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
14 |
0.0005 |
| 710 |
ANAPHYLACTIC REACTION |
26 |
0.0005 |
| 711 |
HYPOPHAGIA |
12 |
0.0005 |
| 712 |
LETHARGY |
27 |
0.0005 |
| 713 |
CARDIAC FLUTTER |
3 |
0.0005 |
| 714 |
ORAL HERPES |
9 |
0.0005 |
| 715 |
DIABETIC KETOACIDOSIS |
11 |
0.0005 |
| 716 |
DYSPNOEA |
259 |
0.0005 |
| 717 |
NEUROTOXICITY |
8 |
0.0005 |
| 718 |
DEVICE RELATED INFECTION |
7 |
0.0005 |
| 719 |
TUMOUR LYSIS SYNDROME |
4 |
0.0005 |
| 720 |
MEDICATION ERROR |
25 |
0.0004 |
| 721 |
BRONCHIECTASIS |
3 |
0.0004 |
| 722 |
OSTEOMYELITIS |
8 |
0.0004 |
| 723 |
HALLUCINATION, AUDITORY |
7 |
0.0004 |
| 724 |
MYOCARDIAL ISCHAEMIA |
5 |
0.0004 |
| 725 |
THROMBOSIS |
35 |
0.0004 |
| 726 |
DIVERTICULITIS |
12 |
0.0004 |
| 727 |
PULMONARY HYPERTENSION |
9 |
0.0004 |
| 728 |
POST PROCEDURAL HAEMORRHAGE |
5 |
0.0004 |
| 729 |
ANGIOEDEMA |
19 |
0.0004 |
| 730 |
RENAL DISORDER |
20 |
0.0004 |
| 731 |
VASCULITIS |
5 |
0.0004 |
| 732 |
NEPHROPATHY |
4 |
0.0004 |
| 733 |
CHOLELITHIASIS |
14 |
0.0004 |
| 734 |
FLANK PAIN |
4 |
0.0004 |
| 735 |
GENERALISED TONIC-CLONIC SEIZURE |
7 |
0.0004 |
| 736 |
PRODUCT STORAGE ERROR |
37 |
0.0004 |
| 737 |
FEBRILE NEUTROPENIA |
28 |
0.0004 |
| 738 |
SUBDURAL HAEMATOMA |
6 |
0.0004 |
| 739 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
4 |
0.0004 |
| 740 |
SEIZURE |
48 |
0.0004 |
| 741 |
HAEMATURIA |
14 |
0.0004 |
| 742 |
CYTOPENIA |
5 |
0.0004 |
| 743 |
RESPIRATORY DEPRESSION |
5 |
0.0004 |
| 744 |
MUSCLE SPASTICITY |
5 |
0.0004 |
| 745 |
WHITE BLOOD CELL COUNT DECREASED |
44 |
0.0004 |
| 746 |
WHEEZING |
24 |
0.0004 |
| 747 |
RENAL INJURY |
12 |
0.0004 |
| 748 |
ARRHYTHMIA |
19 |
0.0004 |
| 749 |
OSTEONECROSIS |
13 |
0.0004 |
| 750 |
CARDIOVASCULAR DISORDER |
10 |
0.0004 |
| 751 |
BLINDNESS |
16 |
0.0004 |
| 752 |
ACUTE MYELOID LEUKAEMIA |
6 |
0.0004 |
| 753 |
HYPERTENSION |
81 |
0.0004 |
| 754 |
HYPERHIDROSIS |
49 |
0.0004 |
| 755 |
POOR QUALITY PRODUCT ADMINISTERED |
4 |
0.0004 |
| 756 |
SUDDEN DEATH |
4 |
0.0004 |
| 757 |
PRODUCT PRESCRIBING ERROR |
9 |
0.0004 |
| 758 |
ASCITES |
11 |
0.0004 |
| 759 |
HEPATIC CIRRHOSIS |
7 |
0.0004 |
| 760 |
NEURALGIA |
9 |
0.0004 |
| 761 |
INFECTION |
53 |
0.0004 |
| 762 |
APHASIA |
11 |
0.0004 |
| 763 |
STEVENS-JOHNSON SYNDROME |
8 |
0.0004 |
| 764 |
SKIN INFECTION |
4 |
0.0004 |
| 765 |
ANAEMIA |
68 |
0.0004 |
| 766 |
HAEMATEMESIS |
9 |
0.0004 |
| 767 |
HEMIPARESIS |
6 |
0.0004 |
| 768 |
HYPOGLYCAEMIA |
17 |
0.0004 |
| 769 |
INTERNAL HAEMORRHAGE |
4 |
0.0003 |
| 770 |
BONE MARROW FAILURE |
7 |
0.0003 |
| 771 |
FLUSHING |
35 |
0.0003 |
| 772 |
LABORATORY TEST ABNORMAL |
10 |
0.0003 |
| 773 |
PSYCHOTIC DISORDER |
10 |
0.0003 |
| 774 |
PULMONARY MASS |
5 |
0.0003 |
| 775 |
BLOOD PRESSURE FLUCTUATION |
8 |
0.0003 |
| 776 |
TREATMENT FAILURE |
27 |
0.0003 |
| 777 |
CHEST PAIN |
60 |
0.0003 |
| 778 |
LYMPHOMA |
5 |
0.0003 |
| 779 |
DERMATITIS ALLERGIC |
4 |
0.0003 |
| 780 |
ABSCESS |
5 |
0.0003 |
| 781 |
SEROTONIN SYNDROME |
6 |
0.0003 |
| 782 |
RASH PAPULAR |
7 |
0.0003 |
| 783 |
AFFECT LABILITY |
3 |
0.0003 |
| 784 |
SENSORY DISTURBANCE |
5 |
0.0003 |
| 785 |
TREMOR |
51 |
0.0003 |
| 786 |
URINARY TRACT INFECTION |
52 |
0.0003 |
| 787 |
PANCYTOPENIA |
17 |
0.0003 |
| 788 |
BLISTER |
17 |
0.0003 |
| 789 |
BLOOD PRESSURE ABNORMAL |
6 |
0.0003 |
| 790 |
DIABETES MELLITUS |
23 |
0.0003 |
| 791 |
CEREBROVASCULAR ACCIDENT |
51 |
0.0003 |
| 792 |
BLOOD POTASSIUM DECREASED |
9 |
0.0003 |
| 793 |
EXTRA DOSE ADMINISTERED |
12 |
0.0003 |
| 794 |
RASH PRURITIC |
16 |
0.0003 |
| 795 |
PALLOR |
8 |
0.0003 |
| 796 |
THERAPEUTIC RESPONSE UNEXPECTED |
13 |
0.0003 |
| 797 |
SWELLING |
27 |
0.0003 |
| 798 |
MOUTH ULCERATION |
6 |
0.0003 |
| 799 |
DYSPHAGIA |
27 |
0.0003 |
| 800 |
BLINDNESS UNILATERAL |
4 |
0.0003 |
| 801 |
PRODUCT DOSE OMISSION IN ERROR |
8 |
0.0003 |
| 802 |
COUGH |
79 |
0.0003 |
| 803 |
THERAPEUTIC RESPONSE DECREASED |
17 |
0.0003 |
| 804 |
OEDEMA |
15 |
0.0003 |
| 805 |
END STAGE RENAL DISEASE |
5 |
0.0003 |
| 806 |
HEART RATE INCREASED |
27 |
0.0003 |
| 807 |
SEDATION |
7 |
0.0003 |
| 808 |
TUBULOINTERSTITIAL NEPHRITIS |
5 |
0.0003 |
| 809 |
HYPONATRAEMIA |
15 |
0.0003 |
| 810 |
HYPOAESTHESIA ORAL |
4 |
0.0003 |
| 811 |
PROTEINURIA |
5 |
0.0003 |
| 812 |
HYPERSENSITIVITY |
48 |
0.0003 |
| 813 |
DELUSION |
4 |
0.0003 |
| 814 |
RASH MACULAR |
9 |
0.0003 |
| 815 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
13 |
0.0002 |
| 816 |
HAEMORRHAGE |
26 |
0.0002 |
| 817 |
FULL BLOOD COUNT DECREASED |
5 |
0.0002 |
| 818 |
PRESYNCOPE |
6 |
0.0002 |
| 819 |
CHEST DISCOMFORT |
25 |
0.0002 |
| 820 |
CARDIOMEGALY |
3 |
0.0002 |
| 821 |
BURNING SENSATION |
17 |
0.0002 |
| 822 |
EXPIRED PRODUCT ADMINISTERED |
8 |
0.0002 |
| 823 |
DYSARTHRIA |
9 |
0.0002 |
| 824 |
ERYTHEMA |
49 |
0.0002 |
| 825 |
HAEMATOCHEZIA |
13 |
0.0002 |
| 826 |
RESPIRATORY TRACT INFECTION |
6 |
0.0002 |
| 827 |
SYNCOPE |
23 |
0.0002 |
| 828 |
FEELING HOT |
14 |
0.0002 |
| 829 |
COLD SWEAT |
4 |
0.0002 |
| 830 |
BLOOD TRIGLYCERIDES INCREASED |
4 |
0.0002 |
| 831 |
LYMPHADENOPATHY |
8 |
0.0002 |
| 832 |
DIABETES MELLITUS INADEQUATE CONTROL |
4 |
0.0002 |
| 833 |
JAUNDICE |
6 |
0.0002 |
| 834 |
THROAT TIGHTNESS |
6 |
0.0002 |
| 835 |
CHROMATURIA |
5 |
0.0002 |
| 836 |
TOXICITY TO VARIOUS AGENTS |
37 |
0.0002 |
| 837 |
DEHYDRATION |
29 |
0.0002 |
| 838 |
UPPER RESPIRATORY TRACT INFECTION |
10 |
0.0002 |
| 839 |
PERICARDIAL EFFUSION |
5 |
0.0002 |
| 840 |
RASH |
94 |
0.0002 |
| 841 |
DISCOMFORT |
13 |
0.0002 |
| 842 |
BLOOD SODIUM DECREASED |
4 |
0.0002 |
| 843 |
COLITIS |
8 |
0.0002 |
| 844 |
CONFUSIONAL STATE |
34 |
0.0002 |
| 845 |
LIP SWELLING |
7 |
0.0002 |
| 846 |
URINARY RETENTION |
7 |
0.0002 |
| 847 |
PRODUCTIVE COUGH |
10 |
0.0002 |
| 848 |
ANOSMIA |
3 |
0.0002 |
| 849 |
TREATMENT NONCOMPLIANCE |
11 |
0.0002 |
| 850 |
ABORTION SPONTANEOUS |
8 |
0.0002 |
| 851 |
FEEDING DISORDER |
4 |
0.0002 |
| 852 |
MYELOSUPPRESSION |
7 |
0.0002 |
| 853 |
INCORRECT DOSE ADMINISTERED |
44 |
0.0002 |
| 854 |
DYSURIA |
7 |
0.0002 |
| 855 |
FAECES DISCOLOURED |
4 |
0.0002 |
| 856 |
SWELLING FACE |
12 |
0.0002 |
| 857 |
SOMNOLENCE |
37 |
0.0002 |
| 858 |
PRODUCT PRESCRIBING ISSUE |
4 |
0.0002 |
| 859 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
13 |
0.0002 |
| 860 |
BLOOD GLUCOSE INCREASED |
34 |
0.0002 |
| 861 |
TYPE 2 DIABETES MELLITUS |
6 |
0.0002 |
| 862 |
ASTHENIA |
67 |
0.0002 |
| 863 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
32 |
0.0002 |
| 864 |
ILLNESS |
18 |
0.0002 |
| 865 |
URTICARIA |
29 |
0.0002 |
| 866 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
8 |
0.0002 |
| 867 |
LACRIMATION INCREASED |
5 |
0.0002 |
| 868 |
BONE DISORDER |
3 |
0.0002 |
| 869 |
RESTLESSNESS |
6 |
0.0002 |
| 870 |
EPILEPSY |
5 |
0.0002 |
| 871 |
EYE SWELLING |
6 |
0.0002 |
| 872 |
MENTAL DISORDER |
7 |
0.0002 |
| 873 |
EPISTAXIS |
12 |
0.0002 |
| 874 |
NERVOUS SYSTEM DISORDER |
5 |
0.0002 |
| 875 |
UNEVALUABLE EVENT |
12 |
0.0002 |
| 876 |
HEAD INJURY |
5 |
0.0002 |
| 877 |
CHRONIC KIDNEY DISEASE |
12 |
0.0002 |
| 878 |
NEUROPATHY PERIPHERAL |
15 |
0.0002 |
| 879 |
CYSTITIS |
5 |
0.0002 |
| 880 |
THROAT IRRITATION |
7 |
0.0002 |
| 881 |
INFLAMMATION |
8 |
0.0002 |
| 882 |
ANXIETY |
44 |
0.0002 |
| 883 |
LOWER RESPIRATORY TRACT INFECTION |
7 |
0.0002 |
| 884 |
BLOOD PRESSURE SYSTOLIC INCREASED |
3 |
0.0002 |
| 885 |
ABDOMINAL DISTENSION |
16 |
0.0002 |
| 886 |
VOMITING |
72 |
0.0002 |
| 887 |
SKIN DISCOLOURATION |
7 |
0.0002 |
| 888 |
IMPAIRED HEALING |
5 |
0.0002 |
| 889 |
BLOOD PRESSURE INCREASED |
23 |
0.0002 |
| 890 |
PERIPHERAL SWELLING |
23 |
0.0001 |
| 891 |
PAIN OF SKIN |
4 |
0.0001 |
| 892 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
5 |
0.0001 |
| 893 |
DECREASED APPETITE |
34 |
0.0001 |
| 894 |
POLLAKIURIA |
6 |
0.0001 |
| 895 |
NEOPLASM PROGRESSION |
5 |
0.0001 |
| 896 |
WOUND |
4 |
0.0001 |
| 897 |
INTENTIONAL DOSE OMISSION |
4 |
0.0001 |
| 898 |
RECTAL HAEMORRHAGE |
6 |
0.0001 |
| 899 |
CARDIAC DISORDER |
13 |
0.0001 |
| 900 |
CELLULITIS |
7 |
0.0001 |
| 901 |
PRODUCT DOSE OMISSION |
9 |
0.0001 |
| 902 |
ABDOMINAL PAIN |
32 |
0.0001 |
| 903 |
OVERDOSE |
29 |
0.0001 |
| 904 |
DYSPNOEA EXERTIONAL |
5 |
0.0001 |
| 905 |
NAUSEA |
105 |
0.0001 |
| 906 |
NEPHROLITHIASIS |
6 |
0.0001 |
| 907 |
TINNITUS |
6 |
0.0001 |
| 908 |
DIARRHOEA |
84 |
0.0001 |
| 909 |
DISTURBANCE IN ATTENTION |
7 |
0.0001 |
| 910 |
SWOLLEN TONGUE |
4 |
0.0001 |
| 911 |
ARTHRITIS |
10 |
0.0001 |
| 912 |
DISORIENTATION |
5 |
0.0001 |
| 913 |
LUNG NEOPLASM MALIGNANT |
5 |
0.0001 |
| 914 |
EYE IRRITATION |
7 |
0.0001 |
| 915 |
MALAISE |
53 |
0.0001 |
| 916 |
AGEUSIA |
3 |
0.0001 |
| 917 |
PRURITUS |
46 |
0.0001 |
| 918 |
HALLUCINATION |
9 |
0.0001 |
| 919 |
OROPHARYNGEAL PAIN |
11 |
0.0001 |
| 920 |
MYOCARDIAL INFARCTION |
20 |
0.0001 |
| 921 |
INTENTIONAL PRODUCT MISUSE |
10 |
0.0001 |
| 922 |
DRUG INTOLERANCE |
11 |
0.0001 |
| 923 |
PALPITATIONS |
13 |
0.0001 |
| 924 |
ACCIDENTAL OVERDOSE |
4 |
0.0001 |
| 925 |
LOSS OF CONSCIOUSNESS |
14 |
0.0001 |
| 926 |
ABNORMAL DREAMS |
3 |
0.0001 |
| 927 |
COGNITIVE DISORDER |
5 |
0.0001 |
| 928 |
BLOOD GLUCOSE DECREASED |
5 |
0.0001 |
| 929 |
ILL-DEFINED DISORDER |
6 |
0.0001 |
| 930 |
DYSKINESIA |
4 |
0.0001 |
| 931 |
DIZZINESS |
49 |
0.0001 |
| 932 |
PAIN |
60 |
0.0001 |
| 933 |
CONSTIPATION |
21 |
0.0001 |
| 934 |
FALL |
32 |
0.0001 |
| 935 |
FEELING ABNORMAL |
23 |
0.0001 |
| 936 |
BACK PAIN |
22 |
0.0001 |
| 937 |
BRONCHITIS |
7 |
0.0001 |
| 938 |
ABDOMINAL PAIN UPPER |
19 |
0.0001 |
| 939 |
HEADACHE |
56 |
0.0001 |
| 940 |
EYE PAIN |
5 |
0.0001 |
| 941 |
MYALGIA |
15 |
0.0001 |
| 942 |
MUSCULAR WEAKNESS |
10 |
0.0001 |
| 943 |
CARDIAC FAILURE CONGESTIVE |
7 |
0.0001 |
| 944 |
HERPES ZOSTER |
5 |
0.0001 |
| 945 |
MULTIPLE SCLEROSIS |
4 |
0.0001 |
| 946 |
STOMATITIS |
5 |
0.0001 |
| 947 |
OEDEMA PERIPHERAL |
10 |
0.0001 |
| 948 |
FATIGUE |
61 |
0.0001 |
| 949 |
SINUSITIS |
8 |
0.0001 |
| 950 |
AMNESIA |
5 |
0.0001 |
| 951 |
SUICIDAL IDEATION |
7 |
0.0001 |
| 952 |
ALOPECIA |
15 |
0.0001 |
| 953 |
PARAESTHESIA |
12 |
0.0001 |
| 954 |
PRODUCT DOSE OMISSION ISSUE |
22 |
0.0001 |
| 955 |
CONTUSION |
7 |
0.0001 |
| 956 |
DEVICE MALFUNCTION |
5 |
0.0001 |
| 957 |
SLEEP DISORDER |
5 |
0.0001 |
| 958 |
BALANCE DISORDER |
6 |
0.0001 |
| 959 |
UNDERDOSE |
5 |
0.0001 |
| 960 |
NASAL CONGESTION |
4 |
0.0001 |
| 961 |
DYSGEUSIA |
5 |
0.0001 |
| 962 |
ADVERSE DRUG REACTION |
6 |
0.0001 |
| 963 |
VERTIGO |
4 |
0.0001 |
| 964 |
VISION BLURRED |
9 |
0.0001 |
| 965 |
ADVERSE EVENT |
6 |
0.0001 |
| 966 |
HOSPITALISATION |
10 |
0.0001 |
| 967 |
INSOMNIA |
16 |
0.0001 |
| 968 |
MUSCLE SPASMS |
11 |
0.0001 |
| 969 |
MULTIPLE SCLEROSIS RELAPSE |
4 |
0.0001 |
| 970 |
INJURY |
4 |
0.0001 |
| 971 |
ARTHRALGIA |
23 |
0.0001 |
| 972 |
PAIN IN EXTREMITY |
16 |
0.0001 |
| 973 |
WEIGHT DECREASED |
15 |
0.0001 |
| 974 |
HYPOAESTHESIA |
8 |
0.0001 |
| 975 |
GAIT DISTURBANCE |
10 |
0.0001 |
| 976 |
INFLUENZA LIKE ILLNESS |
4 |
0.0000 |
| 977 |
DEPRESSION |
11 |
0.0000 |
| 978 |
INFLUENZA |
5 |
0.0000 |
| 979 |
GASTROINTESTINAL DISORDER |
4 |
0.0000 |
| 980 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
9 |
0.0000 |
| 981 |
MEMORY IMPAIRMENT |
6 |
0.0000 |
| 982 |
NASOPHARYNGITIS |
8 |
0.0000 |
| 983 |
MIGRAINE |
4 |
0.0000 |
| 984 |
EMOTIONAL DISTRESS |
5 |
0.0000 |
| 985 |
ASTHMA |
4 |
0.0000 |
| 986 |
INJECTION SITE ERYTHEMA |
4 |
0.0000 |
| 987 |
ACCIDENTAL EXPOSURE TO PRODUCT |
3 |
0.0000 |
| 988 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 989 |
INJECTION SITE PAIN |
4 |
0.0000 |